RhumbLine Advisers
IMCR icon

RhumbLine Advisers’s Immunocore IMCR Stock Holding History

RhumbLine Advisers’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$112K Buy
3,541
+444
+14% +$13.1K ﹤0.01% 3486
2026
Q1 		$93.4K Buy
3,097
+225
+8% +$7.28K ﹤0.01% 3441
2025
Q4 		$99.7K Buy
2,872
+2,332
+432% +$82.3K ﹤0.01% 3476
2025
Q3 		$19.6K Buy
540
+94
+21% +$3.19K ﹤0.01% 3780
2025
Q2 		$14K Sell
446
-30
-6% -$932 ﹤0.01% 3832
2025
Q1 		$14.1K Buy
476
+61
+15% +$1.83K ﹤0.01% 3786
2024
Q4 		$12.2K Hold
415
– – ﹤0.01% 3858
2024
Q3 		$12.9K Buy
415
+60
+17% +$2.18K ﹤0.01% 3861
2024
Q2 		$12K Buy
355
+171
+93% +$8.72K ﹤0.01% 3952
2024
Q1 		$12K Buy
184
+128
+229% +$8.78K ﹤0.01% 3835
2023
Q4 		$3.82K Buy
56
+10
+22% +$520 ﹤0.01% 4022
2023
Q3 		$2.39K Hold
46
– – ﹤0.01% 4093
2023
Q2 		$2.76K Buy
+46
New +$2.63K ﹤0.01% 4173

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

RhumbLine Advisers's IMCR Position: Q2 2026 in Review

RhumbLine Advisers increased its Immunocore (IMCR) stake by 14% in Q2 2026, buying an estimated $13.1K and bringing the position to 3,541 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #3486.

RhumbLine Advisers first reported a position in IMCR in Q2 2023 and has held it in 13 quarters since. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • RhumbLine Advisers held 3,541 shares of Immunocore worth $112K as of Q2 2026.
  • RhumbLine Advisers bought 444 Immunocore shares in Q2 2026, an estimated $13.1K.
  • Immunocore made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #3486 holding.
  • RhumbLine Advisers first reported a position in Immunocore in Q2 2023 and has held it in 13 quarters since.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.